These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 10624080)

  • 1. Pharmacomodulation of endothelial dysfunction: clinical relevance.
    Dalal JJ
    Indian Heart J; 1999; 51(3):338-41. PubMed ID: 10624080
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine improves coronary and peripheral endothelial function in patients with coronary artery disease: are calcium channel blockers acquitted on the charges?
    Celik T; Kursaklioglu H; Iyisoy A; Yuksel C; Isik E
    Int J Cardiol; 2007 Apr; 116(3):406-7. PubMed ID: 16839624
    [No Abstract]   [Full Text] [Related]  

  • 3. Structural and functional manifestations of human atherosclerosis: do they run in parallel?
    Ganz P; Ho JE; Hsue PY
    Eur Heart J; 2009 Jul; 30(13):1556-8. PubMed ID: 19502231
    [No Abstract]   [Full Text] [Related]  

  • 4. Beneficial effects of nifedipine on vasodilator response to acetylcholine in coronary and brachial arteries in the patients with coronary artery disease.
    Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A
    Int J Cardiol; 2006 Nov; 113(3):305-10. PubMed ID: 16386809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium, atherosclerosis and calcium channel blockers.
    Biswas TK
    J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study.
    Lüscher TF; Pieper M; Tendera M; Vrolix M; Rutsch W; van den Branden F; Gil R; Bischoff KO; Haude M; Fischer D; Meinertz T; Münzel T
    Eur Heart J; 2009 Jul; 30(13):1590-7. PubMed ID: 19474053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction: therapy revisited (brief excerpts) (round table discussion on 18/01/2001 at Mumbai).
    Kelly DT; Gandhi MJ
    J Indian Med Assoc; 2001 Mar; 99(3):151-2. PubMed ID: 11478760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated atherosclerosis.
    Samra SS; Walwaikar PP; Morye VK; Gawde AG
    J Indian Med Assoc; 2002 Aug; 100(8):516, 518-21. PubMed ID: 12675186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study].
    Eleuteri E
    Ital Heart J Suppl; 2000 Jun; 1(6):830-1. PubMed ID: 11204017
    [No Abstract]   [Full Text] [Related]  

  • 10. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease].
    Rocha E
    Rev Port Cardiol; 2000 Dec; 19(12):1319-20. PubMed ID: 11220127
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardioprotection quo vadis? The role of nifedipine. 5-6 November 1982, Amsterdam, The Netherlands.
    Eur Heart J; 1983 May; 4 Suppl C():1-135. PubMed ID: 6617691
    [No Abstract]   [Full Text] [Related]  

  • 13. Nifedipine GITS: perspectives beyond blood pressure.
    Cardiovasc J S Afr; 2004; 15(3):145-6. PubMed ID: 15356913
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension, coronary disease and calcium antagonists].
    Dal Palù C
    Cardiologia; 1984; 29(9-10):433-4. PubMed ID: 6543506
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium channel blockers, endothelial dysfunction, and combination therapy.
    Schulman IH; Zachariah M; Raij L
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium blocking as a therapeutic principle].
    Ekelund LG
    Nord Med; 1982 Apr; 97(4):110-3. PubMed ID: 7088691
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium channel blockers and progression of coronary artery disease.
    Henry PD
    Circulation; 1990 Dec; 82(6):2251-3. PubMed ID: 2242548
    [No Abstract]   [Full Text] [Related]  

  • 18. Endothelial dysfunction, angiotensin-converting enzyme inhibitors and calcium antagonists.
    López-Jaramillo P; Casas JP
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S34-7. PubMed ID: 11986891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension.
    Tijssen JG; Hugenholtz PG
    Eur Heart J; 1996 Aug; 17(8):1152-7. PubMed ID: 8869855
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of tirofiban on percutaneous coronary intervention-induced endothelial dysfunction in patients with stable coronary artery disease.
    Warnholtz A; Ostad MA; Heitzer T; Goldmann BU; Nowak G; Munzel T
    Am J Cardiol; 2005 Jan; 95(1):20-3. PubMed ID: 15619388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.